102 related articles for article (PubMed ID: 16949037)
1. Inhibition of PrPSc formation by synthetic O-sulfated glycopyranosides and their polymers.
Yamaguchi S; Nishida Y; Sasaki K; Kambara M; Kim CL; Ishiguro N; Nagatsuka T; Uzawa H; Horiuchi M
Biochem Biophys Res Commun; 2006 Oct; 349(2):485-91. PubMed ID: 16949037
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
3. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
4. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy.
Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A
Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644
[TBL] [Abstract][Full Text] [Related]
6. Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells.
Winklhofer KF; Tatzelt J
Biol Chem; 2000; 381(5-6):463-9. PubMed ID: 10937879
[TBL] [Abstract][Full Text] [Related]
7. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
8. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
[TBL] [Abstract][Full Text] [Related]
9. Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains.
Iwamaru Y; Takenouchi T; Ogihara K; Hoshino M; Takata M; Imamura M; Tagawa Y; Hayashi-Kato H; Ushiki-Kaku Y; Shimizu Y; Okada H; Shinagawa M; Kitani H; Yokoyama T
J Virol; 2007 Feb; 81(3):1524-7. PubMed ID: 17121794
[TBL] [Abstract][Full Text] [Related]
10. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
11. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
13. From microbes to prions the final proof of the prion hypothesis.
Zou WQ; Gambetti P
Cell; 2005 Apr; 121(2):155-7. PubMed ID: 15851020
[TBL] [Abstract][Full Text] [Related]
14. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
[TBL] [Abstract][Full Text] [Related]
15. Cellular heparan sulfate participates in the metabolism of prions.
Ben-Zaken O; Tzaban S; Tal Y; Horonchik L; Esko JD; Vlodavsky I; Taraboulos A
J Biol Chem; 2003 Oct; 278(41):40041-9. PubMed ID: 12871949
[TBL] [Abstract][Full Text] [Related]
16. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes.
Gauczynski S; Nikles D; El-Gogo S; Papy-Garcia D; Rey C; Alban S; Barritault D; Lasmezas CI; Weiss S
J Infect Dis; 2006 Sep; 194(5):702-9. PubMed ID: 16897671
[TBL] [Abstract][Full Text] [Related]
17. Cell culture models to unravel prion protein function and aberrancies in prion diseases.
Bedecs K
Methods Mol Biol; 2008; 459():1-20. PubMed ID: 18576144
[TBL] [Abstract][Full Text] [Related]
18. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
19. Parade of prions.
Schubert C
Nat Med; 2003 Dec; 9(12):1464. PubMed ID: 14647522
[No Abstract] [Full Text] [Related]
20. Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formation.
Gilch S; Kehler C; Schätzl HM
J Mol Biol; 2007 Aug; 371(2):362-73. PubMed ID: 17574575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
